These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28736546)

  • 1. ZB-16, a Novel GPR119 Agonist, Relieves the Severity of Streptozotocin-Nicotinamide-Induced Diabetes in Rats.
    Tyurenkov IN; Kurkin DV; Bakulin DA; Volotova EV; Chafeev MA; Smirnov AV; Morkovin EI
    Front Endocrinol (Lausanne); 2017; 8():152. PubMed ID: 28736546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cerebroprotective activity of metformin, gosogliptin, citicoline and a novel GPR119 agonist in cerebral ischemia under experimental diabetes mellitus].
    Tyurenkov IN; Kurkin DV; Bakulin DA; Volotova EV; Chafeev MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12. Vyp. 2):53-59. PubMed ID: 29411746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16.
    Tyurenkov IN; Kurkin DV; Bakulin DA; Volotova EV; Morkovin EI; Chafeev MA; Karapetian RN
    Front Endocrinol (Lausanne); 2018; 9():543. PubMed ID: 30283402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cycloart-23-ene-3β, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach.
    Badole SL; Mahamuni SP; Bagul PP; Khose RD; Joshi AC; Ghule AE; Bodhankar SL; Raut CG; Khedkar VM; Coutinho EC; Wagh NK
    Eur J Pharmacol; 2013 Jan; 698(1-3):470-9. PubMed ID: 23117087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.
    Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
    Biochem Biophys Res Commun; 2010 Nov; 402(2):280-5. PubMed ID: 20937249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
    Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
    Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Cell Inactivation of
    Panaro BL; Flock GB; Campbell JE; Beaudry JL; Cao X; Drucker DJ
    Diabetes; 2017 Jun; 66(6):1626-1635. PubMed ID: 28254842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angelica dahurica Extracts Improve Glucose Tolerance through the Activation of GPR119.
    Park EY; Kim EH; Kim CY; Kim MH; Choung JS; Oh YS; Moon HS; Jun HS
    PLoS One; 2016; 11(7):e0158796. PubMed ID: 27391814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion.
    Yoshida S; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Sep; 400(3):437-41. PubMed ID: 20804735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of beta cell mass: partial insulin secretory compensation from the residual beta cell population in the nicotinamide-streptozotocin Göttingen minipig after oral glucose in vivo and in the perfused pancreas.
    Larsen MO; Rolin B; Gotfredsen CF; Carr RD; Holst JJ
    Diabetologia; 2004 Nov; 47(11):1873-8. PubMed ID: 15565374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.
    Chu ZL; Jones RM; He H; Carroll C; Gutierrez V; Lucman A; Moloney M; Gao H; Mondala H; Bagnol D; Unett D; Liang Y; Demarest K; Semple G; Behan DP; Leonard J
    Endocrinology; 2007 Jun; 148(6):2601-9. PubMed ID: 17289847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: an overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines.
    Korish AA
    Horm Metab Res; 2014 Jun; 46(6):404-11. PubMed ID: 24627103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dietary Furocoumarin Imperatorin Increases Plasma GLP-1 Levels in Type 1-Like Diabetic Rats.
    Wang LY; Cheng KC; Li Y; Niu CS; Cheng JT; Niu HS
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29084156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice.
    Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Shibasaki M
    Horm Metab Res; 2008 Dec; 40(12):880-6. PubMed ID: 18819058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel GPR119 agonist AS1669058 potentiates insulin secretion from rat islets and has potent anti-diabetic effects in ICR and diabetic db/db mice.
    Oshima H; Yoshida S; Ohishi T; Matsui T; Tanaka H; Yonetoku Y; Shibasaki M; Uchiyama Y
    Life Sci; 2013 Feb; 92(2):167-73. PubMed ID: 23246743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis.
    Lan H; Vassileva G; Corona A; Liu L; Baker H; Golovko A; Abbondanzo SJ; Hu W; Yang S; Ning Y; Del Vecchio RA; Poulet F; Laverty M; Gustafson EL; Hedrick JA; Kowalski TJ
    J Endocrinol; 2009 May; 201(2):219-30. PubMed ID: 19282326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of GPR119 agonists for type 2 diabetes.
    Ohishi T; Yoshida S
    Expert Opin Investig Drugs; 2012 Mar; 21(3):321-8. PubMed ID: 22292451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YH18968, a Novel 1,2,4-Triazolone G-Protein Coupled Receptor 119 Agonist for the Treatment of Type 2 Diabetes Mellitus.
    Han T; Lee BM; Park YH; Lee DH; Choi HH; Lee T; Kim H
    Biomol Ther (Seoul); 2018 Mar; 26(2):201-209. PubMed ID: 29495245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.